🔎 Trials Near Me

Hem › Graft-versus-host-sjukdom › New Jersey

Kliniska studier för Graft-versus-host-sjukdom i New Jersey

4 studier för Graft-versus-host-sjukdom söker deltagare vid platser i New Jersey.

Städer i New Jersey

Officiell studietext (engelska)

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT07359859

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT07216443

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 29 juni 2026 · NCT07006506

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

  • Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only), Middletown
  • Memorial Sloan Kettering Cancer Center @ Bergen (Consent only), Montvale
RekryterarFas 2
Ålder 4 och äldre · Alla kön · Uppdaterad 22 maj 2026 · NCT05675930

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.